Dendritic cell potentials of early lymphoid and myeloid progenitors
Citation
Mg. Manz et al., Dendritic cell potentials of early lymphoid and myeloid progenitors, BLOOD, 97(11), 2001, pp. 3333-3341
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
SICI code
0006-4971(20010601)97:11<3333:DCPOEL>2.0.ZU;2-O
Abstract
It has been proposed that there are at least 2 classes of dendritic cells (
DCs), CD8 alpha (+) DCs derived from the lymphoid lineage and CD8 alpha (-)
DCs derived from the myeloid lineage. Here, the abilities of lymphoid- and
myeloid-restricted progenitors to generate DCs are compared, and their ove
rall contributions to the DC compartment are evaluated. It has previously b
een shown that primitive myeloid-committed progenitors (common myeloid prog
enitors [CMPs]) are efficient precursors of both CD8 alpha (+) and CD8 alph
a (-) DCs in vivo. Here it is shown that the earliest lymphoid-committed pr
ogenitors (common lymphoid progenitors [CLPs]) and CMPs and their progeny g
ranulocyte-macrophage progenitors (GMPs) can give rise to functional DCs in
vitro and in vivo. CLPs are more efficient in generating DCs than their T-
lineage descendants, the early thymocyte progenitors and pro-T cells, and C
MPs are more efficient DC precursors than the descendant GMPs, whereas pro-
B cells and megakaryocyte-erythrocyte progenitors are incapable of generati
ng DCs, Thus, DC developmental potential is preserved during T- but not B-l
ymphoid differentiation from CLP and during granulocyte-macrophage but not
megakaryocyte-erythrocyte development from CMP In vivo reconstitution exper
iments show that CLPs and CMPs can reconstitute CD8 alpha (+) and CD8 alpha
(-) DCs with similar efficiency on a per cell basis, However, CMPs are 10-
fold more numerous than CLPs, suggesting that at steady state, CLPs provide
only a minority of splenic DCs and approximately half the DCs in thymus, w
hereas most DCs, including CD8 alpha (+) and CD8 alpha (-) subtypes, are of
myeloid origin. (Blood, 2001;97:3333-3341) (C) 2001 by The American Societ
y of Hematology.